Acquisitions, Mergers & PartnershipsBioprintingMedical AMSponsored

T&R Biofab and Ethicon bioprinting soft tissue scaffolds for wound treatment

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Bioprinting company T&R Biofab has announced a new collaboration agreement with Ethicon, Inc., a Johnson & Johnson Medical Device Company. The aim of the partnership is to develop a 3D bioprinted soft tissue scaffold for wound treatments, reconstructive surgery and more.

Based in South Korea, T&R Biofab develops and commercializes bioresorbable medical devices and bioinks. The company also pursues research in the area of bioprinted organoids and cell therapeutics. Ethicon, for its part, is a subsidiary of pharmaceutical giant Johnson & Johnson that specializes in wound closure devices and surgical sutures.

Through the collaboration, the companies will leverage their medical expertise to develop soft tissue regeneration and repair products that are differentiated from existing and conventionally manufactured products on the market. The jointly developed products will be produced using T&R Biofab’s 3D platform, which combines polymer, in situ extracellular matrix proteins and 3D bioprinting.

T&R Biofab Ethicon partnership
(Photo: T&R Biofab)

Dr. Wonsoo Yun, CEO of T&R Biofab, commented on the partnership, saying: “We would like to use this opportunity as a stepping stone to generate synergy through the joint R&D agreement with Ethicon, Inc.”

The soft tissue scaffolds developed by the two companies will be intended for use supporting, repairing, elevating or reinforcing anatomical and structural deficiencies. More specifically, the bioprinted tissues could be used for wound treatment applications, such as wound closure and patches; hernia repair; tendon repair; hand surgery; for reinforcing soft tissue in reconstructive or cosmetic surgery; repairing fascial defects; and reconstructing soft tissues.

As per the agreement, Ethicon will be able to “commercially exploit” T&R Biofab’s bioprinting technology with exclusivity. The partnership agreement is being managed by the Johnson & Johnson 3D Printing Center.

Research
Consumer Products AM 2024

This new market study from VoxelMatters provides an in-depth analysis and forecast of polymer and metal AM in the consumer products industry across the three core segments of the additive manufactu...

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.